These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18743)

  • 1. Effects of photolysable 2-azido analogues of adenosine, AMP and ADP on human platelets.
    Cusack NJ; Born GV
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):515-20. PubMed ID: 18743
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of D- and L- enantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido- analogues on human platelets.
    Cusack NJ; Hickman ME; Born GV
    Proc R Soc Lond B Biol Sci; 1979 Nov; 206(1163):139-44. PubMed ID: 42919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of ADP receptors.
    Cusack NJ; Hourani SM; Welford LA
    Adv Exp Med Biol; 1985; 192():29-39. PubMed ID: 3010670
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.
    Bishop GA; Rozenberg MC
    Biochim Biophys Acta; 1975 Mar; 384(1):112-9. PubMed ID: 165830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP- and ADP-induced rat platelet aggregation: significance of plasma in ATP-induced aggregation.
    Haskel EJ; Agarwal KC; Parks RE
    Thromb Haemost; 1980 Feb; 42(5):1580-8. PubMed ID: 7368159
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ; Brossmer R
    Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine analogs and adenine nucleotides on adenosine 5'-diphosphate-induced rat platelet aggregation.
    Agarwal KC; Haskel EJ; Parks RE
    Biochem Pharmacol; 1980 Jun; 29(12):1799-805. PubMed ID: 6250544
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenine nucleotides as tools in platelet studies.
    Maguire MH
    Proc West Pharmacol Soc; 1981; 24():381-4. PubMed ID: 7255483
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP induces desensitisation of equine platelet aggregation responses: studies using ADP beta S, a stable analogue of ADP.
    Poole AW; Heath MF; Evans RJ
    Res Vet Sci; 1993 Mar; 54(2):235-43. PubMed ID: 8460266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation.
    Douglass JG; deCamp JB; Fulcher EH; Jones W; Mahanty S; Morgan A; Smirnov D; Boyer JL; Watson PS
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2167-71. PubMed ID: 18276138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 15. New inhibitors of platelet aggregation. 5'-Phosphate, 5'-phosphorothioate, and 5'-O-sulfamoyl derivatives of 2-substituted adenosine analogues.
    Gough GR; Nobbs DM; Middleton JC; Penglis-Caredes F; Maguire MH
    J Med Chem; 1978 Jun; 21(6):520-5. PubMed ID: 671448
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
    Mateos-Trigos G; Evans RJ; Heath MF
    Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfhydryl analogues of adenosine diphosphate: chemical synthesis and activity as platelet-aggregating agents.
    Stone JV; Singh RK; Horák H; Barton PG
    Can J Biochem; 1976 Jun; 54(6):529-33. PubMed ID: 1276978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deaza analogues of adenosine as inhibitors of blood platelet aggregation.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Petrelli F
    J Pharm Sci; 1984 Mar; 73(3):366-9. PubMed ID: 6716245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
    Lecka J; Gillerman I; Fausther M; Salem M; Munkonda MN; Brosseau JP; Cadot C; Martín-Satué M; d'Orléans-Juste P; Rousseau E; Poirier D; Künzli B; Fischer B; Sévigny J
    Br J Pharmacol; 2013 May; 169(1):179-96. PubMed ID: 23425137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.